1.Localized amyloidosis of seminal vesicle and vas deferens: Report of Two Cases.
Sun Young JUN ; Kyu Rae KIM ; Kyoung Sik CHO ; Jae Y RO
Journal of Korean Medical Science 2003;18(3):447-451
We reported localized amyloidosis involving seminal vesicles and vasa deferentia, which was found in two patients with prostatic adenocarcinoma. A 60-yr-old (Case 1) and a 59-yr-old (Case 2) man came to our hospital with elevation of serum prostate-specific antigen (PSA) and biopsy proven carcinoma, respectively. MRI revealed multiple irregular foci of low signal intensity in the prostates as well as in both seminal vesicles and vasa deferentia on T2-weighted imaging, suggesting prostatic carcinoma with extension to both seminal vesicles and vasa deferentia in both cases. Under the clinical diagnosis of stage III prostatic adenocarcinoma, a radical prostatectomy was performed in both patients. Microscopically, Gleason score 7 adenocarcinoma was observed in both patients. In addition, isolated amyloidosis of both seminal vesicles and vasa deferentia was found without carcinoma involvement. Localized amyloidosis in the seminal vesicles, which is considered as senile process, has been occasionally reported in the autopsy and in the surgical specimens. Amyloid deposition in the vas deferens has also been reported in the literature, however, the deposition mimicking extension of carcinoma has not been reported. In this report, two cases of isolated amyloidosis of the seminal vesicles and vasa deferentia are described with electron microscopic study and literature review.
Adenocarcinoma/complications
;
Amyloidosis/complications/*pathology
;
Human
;
Male
;
Middle Aged
;
Prostatic Neoplasms/complications
;
Seminal Vesicles/*pathology
;
Vas Deferens/*pathology
2.Giant Multilocular Prostatic Cystadenoma Presenting with Obstructive Aspermia.
Jong Pil PARK ; Nam Hoon CHO ; Young Tack OH ; Young Deuk CHOI
Yonsei Medical Journal 2007;48(3):554-556
Giant multilocular prostatic cystadenoma (GMPC) is a rare benign tumor involving the prostate gland. Microscopically, it masquerades phyllodes tumor or transitional zone hyperplasia. We report one case of GMPC arising from the prostate central zone (CZ), presenting with long-standing aspermia associated with seminal vesicle fibrous obliteration.
Aspermia/etiology/*pathology
;
Cystadenoma/complications/*pathology
;
Humans
;
Magnetic Resonance Imaging
;
Male
;
Middle Aged
;
Prostate/*pathology
;
Prostatic Neoplasms/complications/*pathology
3.A case of nephrogenic diabetes insipidus caused by obstructive uropathy due to prostate cancer.
Eun Gyoung HONG ; YuJin SUH ; Yoon Sok CHUNG ; Hyeon Man KIM ; Gyu Tae SHIN ; Do Young CHUNG ; Rae Woong PARK
Yonsei Medical Journal 2000;41(1):150-154
Nephrogenic diabetes insipidus (DI) secondary to chronic urinary tract obstruction is a rare disease. The exact cause is unknown but it is likely that increased collecting duct pressures cause damage to the tubular epithelium, resulting in insensitivity to the action of arginine-vasopressin (AVP). A 77-year-old man complaining of polyuria and polydipsia was treated with alpha glucosidase inhibitor under the impression of polyuria due to diabetes mellitus. But his symptoms did not improve. Water deprivation and AVP administration study revealed that the patient had nephrogenic DI. Urinary tract obstruction due to an enlarged prostate was suggested as a principal cause of nephrogenic DI. The patient underwent transurethral resection of the prostate and bilateral subcapsular orchiectomy. After surgery, the urine osmolarity was normalized and the patient became symptom-free. We report a case of nephrogenic DI due to obstructive uropathy which was cured by surgery eliminating obstruction.
Adenocarcinoma/ultrasonography
;
Adenocarcinoma/radionuclide imaging
;
Adenocarcinoma/pathology
;
Adenocarcinoma/complications*
;
Aged
;
Case Report
;
Constriction, Pathologic/etiology
;
Diabetes Insipidus, Nephrogenic/etiology*
;
Human
;
Male
;
Prostatic Neoplasms/ultrasonography
;
Prostatic Neoplasms/radionuclide imaging
;
Prostatic Neoplasms/pathology
;
Prostatic Neoplasms/complications*
;
Urologic Diseases/etiology*
4.Synchronous primary carcinomas of the bladder and prostate.
Sheng-Hui LEE ; Phei-Lang CHANG ; Shao-Ming CHEN ; Guang-Huan SUN ; Chien-Lun CHEN ; Biing-Yir SHEN ; Ya-Shen WU ; Ke-Hung TSUI
Asian Journal of Andrology 2006;8(3):357-359
AIMTo determine the incidence of adenocarcinoma of the prostate for patients undergoing radical cystoprostatectomy for bladder cancer in Taiwan.
METHODSA total of 248 patients in Taiwan who were histologically confirmed for transitional cell carcinoma of the bladder underwent cystoprostatectomy. Histopathologic evaluation of the prostate specimens sectioned at 5 mm intervals was performed.
RESULTSOf the 248 patients, 10 (4.03%) were found to have prostate cancer. Of the 10 cases of unsuspected prostate cancer, eight proved to be at stage T1 or T2, and two at T3 and T4, respectively. This rate of incidentally found prostate cancer amongst our bladder cancer patients appeared to be lower than that found in bladder cancer patients in similar studies in USA.
CONCLUSIONAlthough the incidence of incidental prostate cancer in patients in Taiwan with bladder cancer is not high compared with that in Western countries, we suggest that digital rectal examination and prostate-specific antigen (PSA) are important screening tools for men with bladder cancer, especially for those aged 60 years and older in Taiwan.
Carcinoma, Transitional Cell ; pathology ; surgery ; Humans ; Male ; Neoplasm Staging ; Prostatectomy ; Prostatic Neoplasms ; complications ; surgery ; Urinary Bladder Neoplasms ; complications ; pathology ; surgery
5.Influence of histological prostatitis on the clinical features of benign prostatic hyperplasia and prostate cancer.
Feng ZHANG ; A SI-MU-JIANG-ABULA ; Li-Dong ZHANG
National Journal of Andrology 2014;20(4):354-358
OBJECTIVETo investigate the influence of histological prostatitis (HP) on the clinical features of benign prostatic hyperplasia (BPH) and prostate cancer (PCa) and its clinical significance.
METHODSWe retrospectively studied the data of 273 cases of BPH and 240 cases of PCa, including age, prostate volume, total prostatic special antigen (tPSA), prostatic special antigen density (PSAD), maximum urinary flow rate (MFR) and acute urinary retention (AUR).
RESULTSTotally, 186 cases of BPH (68.13%) and 45 cases of PCa (18.75%) were complicated by HP, with statistically significant difference between the two groups (P < 0.05). Compared with the patients with BPH only, those complicated by HP showed significantly elevated tPSA, PSAD and total prostate volume (all P < 0.05), decreased MFR (P < 0.05) and increased risk of AUR (P < 0.05). There was no significant difference in the patients' age between the two groups (P > 0.05). The levels of tPSA and PSAD were remarkably higher in the PCa patients complicated by HP than in those with PCa only (all P < 0.05), but no significant differences were found in the other indexes between the two groups (P > 0.05).
CONCLUSIONHP may play a certain role in the progenesis and progression of HP and PCa, but HP is associated more closely with BPH.
Aged ; Disease Progression ; Humans ; Male ; Organ Size ; Prostate ; pathology ; Prostate-Specific Antigen ; blood ; Prostatic Hyperplasia ; etiology ; Prostatic Neoplasms ; complications ; Prostatitis ; complications ; Retrospective Studies ; Urinary Retention ; etiology
6.Electrocardiography series. Non-ischaemic causes of ST segment elevation.
Ivandito KUNTJORO ; Swee Guan TEO ; Kian Keong POH
Singapore medical journal 2012;53(6):367-quiz 371
ST segment elevation is one of the most important electrocardiographic features that need to be recognised. Although ST segment elevation myocardial infarction is one of the main causes of this abnormality, there are other non-ischaemic causes that are also important. We discuss reversible apical ballooning syndrome or Takotsubo cardiomyopathy, pericarditis and a case of ST segment elevation due to 'early repolarisation pattern'.
Cardiology
;
methods
;
Coronary Angiography
;
methods
;
Dyslipidemias
;
complications
;
Electrocardiography
;
methods
;
Female
;
Humans
;
Leukemia, Myeloid, Acute
;
complications
;
Male
;
Middle Aged
;
Myelodysplastic Syndromes
;
complications
;
Myocardial Infarction
;
complications
;
diagnosis
;
Myocardial Ischemia
;
pathology
;
Prostatic Neoplasms
;
complications
;
Respiratory Tract Infections
;
complications
7.Influence of obesity on clinicopathological characteristics in patients with clinically localized prostate cancer.
Yuan-yuan QU ; Bo DAI ; Kun CHANG ; Yun-yi KONG ; Cheng-yuan GU ; Gui-ming ZHANG ; Fang-ning WAN ; Hong-kai WANG ; Hai-liang ZHANG ; Yao ZHU ; Ding-wei YE
Chinese Journal of Surgery 2013;51(12):1089-1093
OBJECTIVETo investigate the influence of anthropometric measures of obesity, including body mass index (BMI), abdominal subcutaneous adipose tissue and visceral adipose tissue, on pathological characteristics in patients with clinically localized prostate cancer.
METHODSFrom January 2006 to March 2013, the 413 patients of prostate cancer who received radical prostatectomy (RP) and their clinical and pathological data had been collected. The median age for the entire cohort was 68 years, which ranged from 48 to 78 years. All patients were diagnosed with prostate cancer before surgery and the Gleason score ranged from 4 to 10 (median 7). Anthropometric measures of abdominal adiposity including anterior abdominal fat, posterior abdominal fat and anteroposterior diameter were measured from the T2 weighted sagittal localization images of MRI scans and subcutaneous adipose tissue and the percentage of visceral adipose tissue were calculated. The patients' clinical and pathologic characteristics across BMI groups were compared used Student's t test for continuous variables or chi-squared test for categorical variables. Moreover, univariable and multivariable logistic regression models were used to address the influence of anthropometric measures of obesity on pathological outcomes.
RESULTSThe BMI ranged from 14.2 to 34.0 kg/m(2) and the median value was 23.8 kg/m(2). The abdominal subcutaneous adipose tissue ranged from 12.6 to 60.3 mm and the median value was 31.4 mm. The percentage of visceral adipose tissue ranged from 71.1% to 92.1% and the median value was 83.8%. In RP specimens, Gleason score ≥ 8 was observed in 141 patients (34.1%), pathological tumor stage was T3a in 69 patients (16.7%) and pathological tumor stage was T3b in 78 patients (18.9%). Positive surgical margin and lymph node involvement were observed in 71(17.2%) and 38(9.2%) patients, respectively. Although univariate analysis showed that BMI ≥ 25 kg/m(2) was associated with pathological Gleason score ≥ 8 (OR = 1.413, P = 0.035), this positive correlation disappeared in multivariate analysis(P = 0.095). In multivariate analysis, the percentage of visceral adipose tissue was significantly associated with pathological Gleason score (OR = 9.618, P = 0.000), extracapsular extension (OR = 6.750, P = 0.002) and seminal vesicle invasion (OR = 4.419, P = 0.007) after adjusting for patient age, PSA level, clinical stage and biopsy Gleason score.
CONCLUSIONSAnthropometric measures of abdominal adiposity was more sophisticated than simple BMI to evaluate the risk of obesity with regard to the aggressiveness of prostate cancer. The percentage of visceral adipose tissue was an independent factor for pathological Gleason score, extracapsular extension and seminal vesicle invasion in RP specimens.
Adiposity ; Aged ; Anthropometry ; Body Mass Index ; Humans ; Intra-Abdominal Fat ; Logistic Models ; Male ; Middle Aged ; Obesity ; complications ; Prostate ; pathology ; Prostatectomy ; Prostatic Neoplasms ; pathology ; Risk Factors
9.Therapeutic efficacy of strontium-89-chloride for bone metastatic tumors without bone pain.
Wei OUYANG ; Jin-hua LIU ; Wei-ying LIU
Journal of Southern Medical University 2007;27(3):390-391
OBJECTIVETo evaluate the safety and efficacy of strontium-89-chloride for management of bone metastases in patients without bone pain.
METHODSFifty-four patients without painful bone metastases were given a single intravenous dose (1.48-2.22 MBq/kg) of strontium-89-chloride, which was repeated once or twice at the interval between 3 and 6 months.
RESULTSThe total response rate was 74.0% in these, and the response rate was significantly lower in patients with focal size>2 cm than in those with focal size CONCLUSIONStrontium-89-chloride is effective and safe for treatment of nonpainful bone metastases.
Adult
;
Aged
;
Aged, 80 and over
;
Bone Neoplasms
;
complications
;
radiotherapy
;
secondary
;
Female
;
Humans
;
Lung Neoplasms
;
pathology
;
Male
;
Middle Aged
;
Pain
;
etiology
;
Prostatic Neoplasms
;
pathology
;
Strontium Radioisotopes
;
therapeutic use
;
Treatment Outcome